CEVEC Pharmaceuticals GmbH (CEVEC), the expert in the production of tailor-made recombinant glycoproteins and gene therapy vectors, today announced that it has signed a non-exclusive license agreement with a leading European veterinary pharmaceutical company for use of its proprietary CAP®Go cells in the development, production and commercialization of two difficult to express recombinant proteins in the field of veterinary vaccines. Under the terms of the agreement, CEVEC provides its expertise in cell line development and in the expression of difficult-to-produce…

GE Healthcare and Oritain are today launching an independent test-based traceability program to authenticate the country of origin of Fetal Bovine Serum (FBS). FBS is a cell growth supplement used in the manufacturing of biopharmaceuticals and vaccines for human health and veterinary purposes, as well as in basic research and drug discovery. Serum plays an important role in the cell-based production of high-quality vaccines and therapeutics for people and animals around the world. Morgan Norris, General Manager for Upstream and…